Opendata, web and dolomites

ARM-B

The ARM-B skin-allergy diagnostics patch is a compact, easy to apply, low-cost allergy testing product.

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 ARM-B project word cloud

Explore the words cloud of the ARM-B project. It provides you a very rough idea of what is the project "ARM-B" about.

invasiveness    microelectrode    ultra    prevalent    quantitative    nausea    solution    malaise    practitioners    biosensors    picomole    penetrating    tine    company    segments    allergens    electrical    accredited    raining    pain    allergy    data    patient    device    reliability    applicable    market    oriented    home    adverse    outcomes    skin    setting    ensures    collated    reaction    mark    consultation    microarray    viz    nl    pricks    consequence    patch    pen    register    microgel    dataset    depths    allergen    minutes    microns    allogen    prick    uses    degree    stick    hundred    vivo    extends    impedance    disc    engineered    offers    clinics    draws    alike    severity    mm    diagnostics    therapist    panels    acquires    free    advantages    specialist    biosensor    clinical    few    reactions    alternative    shaped    healthcare    simplicity    panel    biotech    self    provides    minimising    interpreted    epidermis    sensors    risk    millimetre    innovating    allergic    individual    innovation    arm    patients    markets    purified    structure    intrusive   

Project "ARM-B" data sheet

The following table provides information about the project.

Coordinator
ALLOGEN BIOTECH LIMITED 

Organization address
address: 12 SEAFIELD ROAD CLONTARF
city: DUBLIN
postcode: D03YT25
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Ireland [IE]
 Project website http://www.allogenbiotech.com
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2018
 Duration (year-month-day) from 2018-06-01   to  2018-08-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    ALLOGEN BIOTECH LIMITED IE (DUBLIN) coordinator 50˙000.00

Map

 Project objective

Allogen Biotech is innovating the ARM-B allergy diagnostics patch technology for use in the healthcare sector and home-test markets. The company’s advanced biosensor concept draws on the simplicity and reliability of traditional skin-prick procedures, yet provides improved clinical outcomes and patient experience. The Allogen innovation is engineered as 50 mm stick-on disc-shaped patch, composed of a microarray device, which identify panels of allergic reactions. Each type of allergic response is interpreted as electrical impedance changes at individual biosensors. The allergy specialist acquires the test results in 5 minutes on a wide panel of common or specific allergens. The sensors register the degree of severity of an allergic reaction and may provide further information on specific testing. The ARM-B system offers unique advantages for the allergy therapist and patients alike. The patch device is non-intrusive – no need to pen-mark or prick large areas of skin: ARM-B microarray extends only 30 mm. The tine-microelectrode structure of the biosensor component ensures ultra-low invasiveness, penetrating only a few hundred microns of epidermis, not millimetre skin-prick depths. Therefore the ARM-B test offers a pain free consultation. The in vivo patch uses only picomole/nL, of a purified allergen microgel, minimising the risk of adverse side effects prevalent with skin-pricks – viz. nausea, raining, malaise. The device offers a large allergy dataset, a consequence of the microarray concept. The sensors are quantitative, so data on degree of allergic response or severity is collated. The solution to skin-oriented allergy diagnostics is applicable to several alternative market segments, not only accredited clinics and general practice with specialist allergy practitioners, but also in the self-test or home-use setting. ARM-B is a high value, low-cost solution for allergy diagnostics.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "ARM-B" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "ARM-B" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

CAARESYS (2019)

CAARESYS: vehicle passenger monitoring system based on contactless low emission radio frequency radar.

Read More  

Colourganisms (2020)

Microbial production of custom-made, pure and sustainable anthocyanins

Read More  

TAPPXSSAI (2019)

Development of a system for automatic ad insertion into on-demand streaming video to provide new monetization mechanisms to the media industry

Read More